NCCR AntiResist panel discussion

International Day of Women and Girls in Science

Disperazol to be showcased at Bionow’s 2024 BioInfect Conference

Antibiotic resistance and climate change

MediWales Innovation Awards 2023

Doing the maths: Disperazol® = cystic fibrosis – (biofilms+AMR)

MediWales Members' Showcase 2023

Biophys at the Nordic Innovation Fair 2023

Fungal Diseases Awareness Week: Candida

Diagnosing infectious disease – a poster child for preventive medicine if we can make the numbers work

Co-authors in PLOS Computational Biology

Disperazol® features at the 7th AMR Conference in Basel

Meet us at BioWales in London 2023

A look back at Biophys in Science in Parliament 2022

Wearable diagnostics paving the way in Biotechnology

Biotechnology Advances in Diabetes Diagnosis

Understanding breast cancer and biotechnology

How diagnostics have been improved for Urologic conditions

How biotechnology can help the climate emergency

How is biotechnology used with marine life?

Scientific Communication - A Biophys Speciality

COVID-19 and In Vitro Diagnostics – how it worked

Biophys present at BioWales in London 2022

Find us at BioWales in London this month

Global Life Science's Latest R&D Report Card

What is Biotechnology?

Biophys- Making the Business Work

Biophys Present Outstanding Achievement Award at MediWales Innovation Awards 2021

Resources to improve Alzheimer’s Disease management globally

The road less taken - Rethinking commercialisation of innovative R&D

Take a look at NewsMedical’s Alzheimer’s disease newsletter

Revisiting association, cause and effect in Alzheimer’s disease

Biophys attends Virtual AMR Innovation Mission 2021

Biophys Ltd features in Science in Parliament Spring 2021 journal

Prof Bryan Hanley joins ILSI Europe's Board of Directors

Mapping the UK microbiome landscape

The hard work of getting back to work

Being able to resume operations is good news for businesses

Antibiotics and COVID-19 – a treatment conundrum?

The story of Biophys continues